ASHLEY WILLIAMSON: Open Payments
NPI 1023582301 · ANNISTON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,164 in 50 payments from 16 companies in 2025. Trend: 2023 $16 · 2024 $1,055 · 2025 $1,164
Food & beverage: $1,164
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $198 |
| Fresenius USA Marketing, Inc. | 10 | $160 |
| AKEBIA THERAPEUTICS INC | 4 | $114 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $105 |
| ANI Pharmaceuticals, Inc. | 3 | $86 |
| Vifor Pharma, Inc. | 3 | $80 |
| Calliditas Therapeutics US Inc. | 3 | $78 |
| Travere Therapeutics, Inc. | 3 | $77 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
Products named: Fabhalta, VELPHORO, Kerendia, Auryxia, PURIFIED CORTROPHIN GEL, Veltassa, TARPEYO, JYNARQUE.
Industry payments across AL — which companies pay providers there.
